04-09-2010: CSM and its subsidiary Purac announced the official start of construction for its new Lactide plant in Thailand. The groundbreaking ceremony was held at the existing Purac site in Rayong, Thailand. The plant will produce monomers for bioplastics. The investment is driven by CSM’s commitment to play a leading role in the development of the market for lactic acid based bioplastics i.e Poly lactic Acid (PLA). This market is highly attractive as PLA contributes, with commercially viable products, to a significantly lower carbon dioxide (CO2) footprint than the traditional oil based plastics. The investment for this new 75,000 tons Lactide plant will be EUR 45 million (Baht 2 billion). The new plant will be ready for start up in the second half of 2011 to meet our current level of demand and to accelerate market development.
Gerard Hoetmer, CEO of CSM comments: “This investment will take us to the next step in our bio-plastics program, where our proprietary technology gives us a considerable opportunity together with our partners, to grow the PLA market. Even a 1% share of the 250 million ton plastics market represents a huge opportunity for our products and our company.”
The products are aimed for a broad segment of today’s plastics market and enables Purac’s partners to produce bioplastic products with a high heat resistance up to 180 degrees Celsius/ degrees 266 Fahrenheit.
Gerard Hoetmer continues: “We have made good progress in co-developing commercial applications for this next generation of PLA, such as in the packaging, foam and fiber industries. This is supported by the drive to reduce CO2 with commercially attractive products. Both from a market and technology perspective, PLA will continue to gain attractiveness compared to traditional oil-based plastics through further investments in future generations of products.”
The new plant will be located at the existing Purac site in Thailand. The capacity of the Lactides plant will be 75,000 tons. It is designed to produce both L-Lactides and D-Lactides, made out of lactic acid sourced from the existing Purac plants.
BASF SE and Purac, a subsidiary of CSM nv, announced the start of negotiations to form a joint venture for the production of bio-based succinic acid. The companies have been conducting research under a joint development agreement on bio-based succinic acid since 2009. The complementary stre ... more
CSM's subsidiary Purac and Indorama Ventures PLC (IVL) are in discussions to set up a Polylactic acid (PLA) manufacturing facility in Thailand, with an initial capacity of 10,000 tons per annum being raised to 100,000 tons per annum after developing application specific grades. This produc ... more
CSM and its subsidiary Purac announced the official start of construction for its new Lactide plant in Thailand. The groundbreaking ceremony was held at the existing Purac site in Rayong, Thailand. The plant will produce monomers for bioplastics. The investment is driven by CSM’s commitment ... more
CSM is the largest supplier of bakery products worldwide and is global market leader in lactic acid and lactic acid derivatives. CSM produces and distributes an extensive range of bakery products and ingredients for artisan and industrial bakeries and for in-store as well as out-of-home mar ... more
BASF SE and Purac, a subsidiary of CSM nv, announced the start of negotiations to form a joint venture for the production of bio-based succinic acid. The companies have been conducting research under a joint development agreement on bio-based succinic acid since 2009. The complementary stre ... more
CSM's subsidiary Purac and Indorama Ventures PLC (IVL) are in discussions to set up a Polylactic acid (PLA) manufacturing facility in Thailand, with an initial capacity of 10,000 tons per annum being raised to 100,000 tons per annum after developing application specific grades. This produc ... more
Purac announces the investment in a new manufacturing facility for its biomedical polymers. The plant is meant to support the growing resorbable polymers business of Purac Biomaterials. Purac currently operates a plant for biomedical polymers in The Netherlands. This second facility will be ... more
PURAC is the worldwide market leader in lactic acid, lactic acid derivatives and lactides. PURAC has over 70 years of experience in the development, manufacturing and marketing of these products in a broad range of industries. PURAC operates production plants in the USA, the Netherlands, Sp ... more